Treatment With Dalcetrapib Modifies the Relationship Between High-Density Lipoprotein Cholesterol and C-Reactive Protein

J Am Coll Cardiol. 2016 Dec 6;68(22):2488-2490. doi: 10.1016/j.jacc.2016.09.932.
No abstract available

Publication types

  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Amides
  • Anticholesteremic Agents / administration & dosage
  • C-Reactive Protein / analysis*
  • Cholesterol Ester Transfer Proteins / antagonists & inhibitors
  • Cholesterol, HDL / analysis*
  • Coronary Disease* / blood
  • Coronary Disease* / prevention & control
  • Esters
  • Female
  • Humans
  • Male
  • Middle Aged
  • Outcome Assessment, Health Care
  • Sulfhydryl Compounds / administration & dosage*

Substances

  • Amides
  • Anticholesteremic Agents
  • CETP protein, human
  • Cholesterol Ester Transfer Proteins
  • Cholesterol, HDL
  • Esters
  • Sulfhydryl Compounds
  • dalcetrapib
  • C-Reactive Protein